Readnour Robin Shane sold ANTX
March 19, 2026 · Form 4 insider transaction
Readnour Robin Shane sold 20,724 shares of AN2 Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,724
Price
N/A
Total value
N/A
InsiderReadnour Robin Shane
RoleDirector
SecurityStock Option (right to buy)
Transaction codeD: Disposition to the issuer
Transaction dateMarch 19, 2026
Filing dateMarch 23, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.; The option is fully vested.